secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2024-11-04T23:59:59+00:00
Accession:  0000950170-24-120902
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics appoints Michael Kaseta to Board of Directors
----------------------------------------------------------------

- Michael Kaseta, CFO/COO of Liquidia, appointed to Heron's Board effective Nov. 4, 2024.
- Kaseta brings biopharma finance and commercial expertise; served as CFO at Aerami and Aralez.
- Previously CFO of Sanofi North America, managing a $10B business across 100+ products.
- Will receive standard non-employee director compensation and enter indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/0000950170-24-120902-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/hrtx-20241104.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-120902

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer